Venapunction

OTHER6 trials

Sponsors

Amsterdam UMC, location VUmc, Maastricht University Medical Center, Radboud University Medical Center, Noordwest Ziekenhuisgroep, nvt

Conditions

Breast Advanced MalignanciesColorectum Advanced MalignanciesDiastolic dysfunction of the heart, eventually evolving into heart failure with preserved ejection fraction, Coronary vascular disease, including both macro- and microvascular coronary diseaseGonadal DysgenesisHELLP SyndromeInfection, BacterialInfertility, FemaleIntrauterine Growth Restriction

Unknown Phase

Optimization of Systemic Treatment Strategies in Elderly Patients With Advanced Solid Malignancies

CompletedNCT01956747

Amsterdam UMC, location VUmcBreast Advanced Malignancies, Colorectum Advanced Malignancies, Prostate Advanced Malignancies

Start: 2013-07-31End: 2019-12-01Updated: 2020-11-20

Active, not recruitingNL-OMON21717

nvtDiastolic dysfunction of the heart, eventually evolving into heart failure with preserved ejection fraction, Coronary vascular disease, including both macro- and microvascular coronary disease

Start: 2016-06-01Target: 3000Updated: 2024-06-11

Women Specific Cardiac Recovery After Preeclampsia

Maastricht University Medical CenterHELLP Syndrome, Intrauterine Growth Restriction, Pre-Eclampsia +1

Start: 2016-06-30End: 2022-06-30Target: 290Updated: 2018-08-27

Turner Syndrome Minipuberty Study

Radboud University Medical CenterGonadal Dysgenesis, Infertility, Female, Ovarian Diseases +4

Start: 2020-02-01End: 2024-12-01Target: 30Updated: 2023-11-29

Vaccination, Immunity and Aging Research

Active, not recruitingNL-OMON23996

Start: 2020-09-01Target: 200Updated: 2024-02-28

Target Attainment of Cefuroxim

Noordwest ZiekenhuisgroepInfection, Bacterial, Kinesics

Start: 2022-01-15End: 2023-01-01Target: 45Updated: 2022-04-08